Finance

Lists
Why is HNSA down 5,71%?
Dive Deeper
HNSA:STO
Hansa Biopharma AB
38,94 SEK
-5,71%
(-2,36) 1D
10 ნოე, 17:29:55 GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
41,52 SEK
High
42,62 SEK
Low
38,90 SEK
Mkt. cap
3,96 მლრდ.
Avg. vol.
474,41 ათ.
Volume
1,01 მლნ.
52-wk high
48,22 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 მლნ.
No. of employees
131
Open
41,52 SEK
High
42,62 SEK
Low
38,90 SEK
Mkt. cap
3,96 მლრდ.
Avg. vol.
474,41 ათ.
Volume
1,01 მლნ.
52-wk high
48,22 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 მლნ.
No. of employees
131
News stories
From web sources and news partners
About Hansa Biopharma AB
CEOსორენ ტულსტრუპი
Employees131
Founded2007
Headquarters-
SectorHealth Care
Industry-
Websitehansabiopharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
30,80 მლნ.
75,99 მლნ.
34,57 მლნ.
48,10 მლნ.
Cost of goods sold
20,11 მლნ.
24,66 მლნ.
13,78 მლნ.
22,33 მლნ.
Cost of revenue
20,11 მლნ.
24,66 მლნ.
13,78 მლნ.
22,33 მლნ.
Research and development expenses
70,21 მლნ.
74,43 მლნ.
57,34 მლნ.
67,87 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88,41 მლნ.
101,62 მლნ.
105,56 მლნ.
118,93 მლნ.
Operating expense
160,41 მლნ.
176,02 მლნ.
162,90 მლნ.
186,83 მლნ.
Total operating expenses
180,52 მლნ.
200,67 მლნ.
176,68 მლნ.
209,16 მლნ.
Operating income
-149,71 მლნ.
-124,68 მლნ.
-142,11 მლნ.
-161,06 მლნ.
Other non operating income
-
-
1,38 მლნ.
-30,53 მლნ.
EBT including unusual items
-147,56 მლნ.
-169,50 მლნ.
-195,87 მლნ.
-259,86 მლნ.
EBT excluding unusual items
-147,56 მლნ.
-169,50 მლნ.
-195,87 მლნ.
-259,86 მლნ.
Income tax expense
693,00 ათ.
396,00 ათ.
453,00 ათ.
677,00 ათ.
Effective tax rate
-0,47%
-0,23%
-0,23%
-0,26%
Other operating expenses
1,79 მლნ.
-34,00 ათ.
-
28,00 ათ.
Net income
-148,26 მლნ.
-169,90 მლნ.
-196,32 მლნ.
-260,54 მლნ.
Net profit margin
-481,29%
-223,58%
-567,89%
-541,71%
Earnings per share
-1,75
-1,62
-1,93
-2,26
Interest and investment income
10,28 მლნ.
-
2,55 მლნ.
3,20 მლნ.
Interest expense
-10,23 მლნ.
-208,06 მლნ.
-28,90 მლნ.
-58,48 მლნ.
Net interest expenses
49,00 ათ.
-208,06 მლნ.
-26,35 მლნ.
-55,27 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-149,07 მლნ.
-124,05 მლნ.
-141,48 მლნ.
-149,39 მლნ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები